ANAB insider transactions
AnaptysBio Inc. (ANAB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ANAB
- SEC Form 3 filed by new insider Gray Susannah3 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Schmid John P.4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 3 filed by new insider Anaptysbio, Inc3 - ANAPTYSBIO, INC (0001370053) (Reporting)
- SEC Form 4 filed by Faga Daniel4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J exercised 10,000 shares at a strike of $29.70 and sold $540,000 worth of shares (10,000 units at $54.00) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Marquet Magda sold $530,531 worth of shares (11,000 units at $48.23) and exercised 11,000 shares at a strike of $26.11 (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Chief Medical Officer Lizzul Paul F. converted options into 8,525 shares and sold $163,192 worth of shares (3,650 units at $44.71), increasing direct ownership by 13% to 42,088 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF FINANCIAL OFFICER Mulroy Dennis converted options into 6,700 shares and sold $112,446 worth of shares (2,515 units at $44.71), increasing direct ownership by 24% to 21,852 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J converted options into 5,888 shares and sold $98,809 worth of shares (2,210 units at $44.71), increasing direct ownership by 40% to 12,835 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- President, CEO Faga Daniel converted options into 26,838 shares and sold $638,504 worth of shares (14,281 units at $44.71), increasing direct ownership by 3% to 479,344 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J converted options into 5,545 shares and sold $439,200 worth of shares (9,639 units at $45.56), decreasing direct ownership by 31% to 9,157 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Chief Medical Officer Lizzul Paul F. sold $100,821 worth of shares (2,235 units at $45.11) and converted options into 6,145 shares, increasing direct ownership by 12% to 37,213 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- President, CEO Faga Daniel sold $415,102 worth of shares (9,202 units at $45.11) and converted options into 17,850 shares, increasing direct ownership by 2% to 466,787 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF FINANCIAL OFFICER Mulroy Dennis converted options into 5,245 shares and sold $86,070 worth of shares (1,908 units at $45.11), increasing direct ownership by 23% to 17,667 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Fenton Dennis M4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Jain Rita4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Marquet Magda4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Renton Hollings4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Schmid John P.4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Ware J. Anthony4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Orwin John A4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- President, CEO Faga Daniel converted options into 34,677 shares and sold $662,267 worth of shares (15,309 units at $43.26), increasing direct ownership by 4% to 458,139 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF FINANCIAL OFFICER Mulroy Dennis sold $145,483 worth of shares (3,363 units at $43.26) and converted options into 8,292 shares, increasing direct ownership by 52% to 14,330 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Chief Medical Officer Lizzul Paul F. converted options into 10,555 shares and sold $182,514 worth of shares (4,219 units at $43.26), increasing direct ownership by 23% to 33,303 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J converted options into 7,287 shares and sold $129,045 worth of shares (2,983 units at $43.26), increasing direct ownership by 48% to 13,251 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Ware J. Anthony sold $193,342 worth of shares (3,900 units at $49.58), decreasing direct ownership by 29% to 9,630 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Schmid John P. disposed of $564,468 worth of shares (11,068 units at $51.00) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Chief Medical Officer Lizzul Paul F. exercised 1,500 shares at a strike of $18.50 and sold $75,000 worth of shares (1,500 units at $50.00) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF FINANCIAL OFFICER Mulroy Dennis exercised 10,000 shares at a strike of $20.16 and sold $500,000 worth of shares (10,000 units at $50.00) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J exercised 10,000 shares at a strike of $14.02 and sold $510,000 worth of shares (10,000 units at $51.00) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J exercised 22,500 shares at a strike of $16.07 and sold $1,027,425 worth of shares (22,641 units at $45.38), decreasing direct ownership by 2% to 8,947 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF FINANCIAL OFFICER Mulroy Dennis exercised 10,000 shares at a strike of $20.16 and sold $705,333 worth of shares (15,725 units at $44.85), decreasing direct ownership by 38% to 9,401 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J exercised 5,000 shares at a strike of $14.02 and sold $238,960 worth of shares (8,240 units at $29.00), decreasing direct ownership by 26% to 9,088 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Orwin John A converted options into 1,300 shares, increasing direct ownership by 14% to 10,665 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Renton Hollings exercised 10,231 shares at a strike of $6.93 and sold $200,714 worth of shares (10,231 units at $19.62) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Renton Hollings exercised 20,925 shares at a strike of $6.93 and sold $493,191 worth of shares (20,925 units at $23.57) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Fenton Dennis M sold $72,270 worth of shares (3,015 units at $23.97), decreasing direct ownership by 38% to 4,965 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Renton Hollings sold $72,270 worth of shares (3,015 units at $23.97), decreasing direct ownership by 38% to 4,965 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Jain Rita converted options into 7,330 shares, increasing direct ownership by 162% to 11,864 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Fenton Dennis M converted options into 6,030 shares, increasing direct ownership by 309% to 7,980 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Marquet Magda converted options into 6,030 shares, increasing direct ownership by 155% to 9,930 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Orwin John A converted options into 6,030 shares, increasing direct ownership by 181% to 9,365 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Renton Hollings converted options into 6,030 shares, increasing direct ownership by 309% to 7,980 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Schmid John P. converted options into 6,030 shares, increasing direct ownership by 13% to 52,267 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Ware J. Anthony converted options into 6,030 shares, increasing direct ownership by 80% to 13,530 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Schmid John P. acquired $201,241 worth of shares (11,068 units at $18.18) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Schmid John P. exercised 42,337 shares at a strike of $6.50, increasing direct ownership by 1,086% to 46,237 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Chief Medical Officer Lizzul Paul F. covered exercise/tax liability with 6,597 shares and converted options into 16,700 shares, increasing direct ownership by 65% to 25,643 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF FINANCIAL OFFICER Mulroy Dennis covered exercise/tax liability with 5,461 shares and converted options into 13,538 shares, increasing direct ownership by 141% to 13,802 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- CHIEF LEGAL OFFICER Loumeau Eric J covered exercise/tax liability with 5,211 shares and converted options into 12,833 shares, increasing direct ownership by 225% to 11,003 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Fenton Dennis M4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Jain Rita4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Marquet Magda4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Orwin John A4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Renton Hollings4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Schmid John P.4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- SEC Form 4 filed by Director Ware J. Anthony4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- President, CEO Faga Daniel converted options into 52,528 shares and covered exercise/tax liability with 19,420 shares, increasing direct ownership by 8% to 436,466 units (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Ecor1 Capital, Llc bought $1,099,642 worth of shares (85,098 units at $12.92) (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)
- Director Renton Hollings sold $250,000 worth of shares (10,000 units at $25.00) and exercised 10,000 shares at a strike of $6.93 (SEC Form 4)4 - ANAPTYSBIO, INC (0001370053) (Issuer)